Resilience in East Asian Immigrants for Advance Care Planning Discussions

February 16, 2026 updated by: University of Illinois at Chicago

Development of a Culturally Tailored Digital Resilience-Building Intervention for East Asian Immigrants With Cancer to Facilitate Advance Care Planning Discussions

The purpose of the study is to develop a culturally tailored digital resilience-building intervention to help East Asian immigrants engage in advance care planning discussions with their family caregivers.

Study Overview

Detailed Description

Advance care planning (ACP) is a process to facilitate decision-making for future care and document values and preferences. However, the advance directive completion rates in East Asian Americans are low, which may extend to disparities in end-of-life care, including rates of hospice use and prevalence of unwanted aggressive treatments. To address this, this study uses information technology to develop a culturally tailored digital resilience-building intervention with and for East Asian immigrants to help them engage in ACP discussions. There are two aims of this study: (1) Conduct semi-structured interviews with a total of 30 religious leaders to identify the barriers and facilitators associated with discussing ACP and death-related topics with immigrants from China/Taiwan, Japan, and Korea and (2) Develop a culturally tailored digital resilience-building intervention using think-aloud interviews with 27 pairs of East Asian immigrants with cancer and their family caregivers (9 pairs each for immigrants from China/Taiwan, Japan, and Korea).

Study Type

Observational

Enrollment (Estimated)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Li-Ting H. Longcoy
  • Phone Number: 312-996-3024
  • Email: liting@uic.edu

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60607
        • Recruiting
        • University of Illinois Chicago
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Religious leaders providing spiritual care to Asian Americans/immigrants or Asian Americans/immigrants living with cancer

Description

Inclusion Criteria for Religious Leaders:

  • Age ≥ 18 years
  • Serving as a chaplain or religious leader at a healthcare setting or religious organization
  • Having experience providing pastoral or spiritual care to Chinese, Japanese, and Korean Americans in the US
  • Being able to read and respond to questions in English, Mandarin, Cantonese, Japanese, or Korean.

Exclusion criteria: Not willing to provide consent.

Inclusion Criteria for Patients:

  • Age ≥ 18 years
  • Having a cancer diagnosis
  • Likely self-identifying as a Chinese, Japanese, or Korean American/immigrant
  • Being able to read and respond to questions in either English, Mandarin, Japanese, Korean, or Chinese dialects, such as Cantonese, Shanghai, Taishanese, or Taiwanese.

Exclusion Criteria for Patients:

  • Having cognitive impairment per the Short Portable Mental Status Questionnaire with more than three errors

Inclusion Criteria for Family Caregivers:

  • Age ≥ 18 years
  • Being able to read and respond to questions in either English, Mandarin, Japanese, Korean, or Chinese dialects, such as Cantonese, Shanghai, Taishanese, or Taiwanese
  • Having a family member who is likely to self-identify as a Chinese, Japanese, or Korean American/immigrant and has been diagnosed with cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Culturally Tailored Digital Resilience-Building
The culturally tailored resilience-building materials will be provided to East Asian immigrants with cancer and their family caregivers.
The Culturally Tailored Digital Resilience-Building materials include an introduction to advance care planning and resilience skills that specifically address cultural beliefs and barriers.
Religious leaders
Religious leaders providing spiritual care to Asian Americans
Semi-structured interviews with religious leaders who provide spiritual care to Asian Americans/immigrants.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Usability
Time Frame: Immediately at the end of the think-aloud interview
Use the System Usability Scale (range: 0-100) to assess the usability of the intervention. Higher scores indicate greater perceived usability by users.
Immediately at the end of the think-aloud interview

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability
Time Frame: Immediately at the end of the think-aloud interview
Use the Acceptability E-scale to assess the acceptability of the intervention. Scale total scores range from 6 to 30, and higher scores indicate greater acceptance for the proposed intervention.
Immediately at the end of the think-aloud interview

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Religious leaders experience
Time Frame: Immediately at the end of the interview
An in-depth understanding of religious leaders' perspectives on barriers and facilitators to discussing death-related topics with immigrants from East Asia.
Immediately at the end of the interview

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Li-Ting H. Longcoy, University of Illinois Chicago College of Nursing

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 27, 2023

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

September 6, 2023

First Submitted That Met QC Criteria

September 6, 2023

First Posted (Actual)

September 13, 2023

Study Record Updates

Last Update Posted (Actual)

February 18, 2026

Last Update Submitted That Met QC Criteria

February 16, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2023-0560
  • KC_Awd_114452 (Other Identifier: University of Illinois at Chicago)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neoplasms

Clinical Trials on Culturally Tailored Digital Resilience-Building

Subscribe